Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-01 Welgus Howard G. Director Exercise or conversion +556 $0.58 $323 182,452
2021-09-01 Welgus Howard G. Director Exercise or conversion +4,444 $1.68 $7K 186,896
2021-09-01 Welgus Howard G. Director Sale −4,200 $20.71 $87K 182,696
2021-09-01 Welgus Howard G. Director Sale −800 $21.28 $17K 181,896
2021-09-01 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −556 25,106
2021-09-01 Welgus Howard G. Director Exercise or conversion · Stock Option (Right to Buy) −4,444 9,223
2021-08-05 Watanabe Todd Franklin President and CEO Exercise or conversion +1,000 $1.68 $2K 595,779
2021-08-05 Watanabe Todd Franklin President and CEO Sale −1,000 $20.81 $21K 594,779
2021-08-05 Watanabe Todd Franklin President and CEO Exercise or conversion · Stock Option (Right to Buy) −1,000 128,635

Page 35 of 35 · 689 trades